Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott Laboratories to Acquire IDEV Technologies


Monday, 15 Jul 2013 10:50am EDT 

Abbott Laboratories announced that it has entered into an agreement to purchase IDEV Technologies, a privately held company focused on developing medical devices for use by interventional radiologists, vascular surgeons and cardiologists. Under the terms of the agreement, Abbott will acquire all outstanding equity of IDEV Technologies for $310 million net of cash and debt. IDEV Technologies is headquartered in Webster,Texas. The transaction is expected to close by the end of the year. The transaction is subject to customary closing conditions, including antitrust clearances. 

Company Quote

43.38
0.48 +1.12%
17 Sep 2014